[1] |
Vidinov K, Nikolova D. Familial papillary thyroid carcinoma (FPTC): a retrospective analysis in a sample of the Bulgarian population for a 10-year period[J]. Endocr Pathol, 2017, 28(1):54-59.
|
[2] |
Che HY, Guo HY, Si XW, et al. Additive effect by combination of Akt inhibitor, MK-2206, and PDGFR inhibitor, tyrphostin AG 1296, in suppressing anaplastic thyroid carcinoma cell viability and motility[J]. Onco Targets Ther, 2014, 7:425-432.
|
[3] |
袁超,刘恒超,胡永全, 等. 131治疗分化型甲状腺癌术后肺转移的临床研究[J]. 放射免疫学杂志, 2013, 26(2):130-133.
|
[4] |
Fu H, Ma C, Guan W, et al. Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma[J]. Onco Targets Ther, 2016, 9:1519-1523.
|
[5] |
Lei J, Zhu J, Li Z, et al.Surgical procedures for papillary thyroid carcinoma located in the thyroid isthmus: an intention-to-treat analysis[J]. OncoTargets Ther, 2016, 9:5209-5216.
|
[6] |
青春,朱云枝,汪开明, 等. 小剂量131治疗24例肺转移性甲状腺癌临床分析[J]. 中华实用诊断与治疗杂志, 2011, 25(12):1169-1173.
|
[7] |
Zayed AA, Ali MK, Jaber OI, et al.Is Hashimoto’s thyroiditis a risk factor for medullary thyroid carcinoma? Our experience and a literature review[J]. Endocrine, 2015, 48(2):629-636.
|
[8] |
李素平,游金辉,温琥玲, 等. 131 -SPECT/CT断层融合显像在分化型甲状腺癌分期中的价值[J]. 川北医学院学报, 2012, 27(2):109-111.
|
[9] |
田志远,吴庆超. 甲状腺癌淋巴结转移检测方法研究进展[J]. 中华实用诊断与治疗杂志, 2013, 27(11):1051-1053.
|
[10] |
Ho WL, Zacharin MR. Thyroid carcinoma in children, adolescents and adults, both spontaneous and after childhood radiation exposure[J]. Eur J Pediatr, 2016, 175(5):677-683.
|
[11] |
Iliadou PK, Effraimidis G, Konstantinos M, et al. Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents[J]. Eur J Endocrinol, 2015, 173(6):827-833.
|
[12] |
Kalender E, Zeki Celen Y, Elboga U, et al.Lung metastases inpatients with differentiated thyroid carcinoma and evaluation of responseto radioiodine therapy[J]. Rev Esp Med Nucl Imagen Mol, 2012, 31(6):328-331.
|
[13] |
Kand P, Basu S. Clinicoradiological characteristics of patients with differentiated thyroid carcinoma and renal metastasis: case series with follow up[J]. J Laryngol Otol, 2014, 128(2):203-208.
|
[14] |
Murphy C, Schwalb H, Berlangieri S, et al.Intraluminal superior vena cava metastasis in a patient with poorly differentiated thyroid carcinoma[J]. J Clin Oncol, 2015, 33(32):e119-e121.
|
[15] |
Lenzi R, Marchetti M, Muscatello L. Incidental nodal metastasis of differentiated thyroid carcinoma in neck dissection specimens from head and neck cancer patients[J]. J Laryngol Otol, 2017, 131(4):368-371.
|
[16] |
Yang H, Chen Z, Wu M, et al. Remarkable response in 2 cases of advanced poorly differentiated thyroid carcinoma with liposomal doxorubicin plus cisplatin[J]. Cancer Biol Ther, 2016, 17(6):693-697.
|
[17] |
Basu S, Pantvaidya G, Malvadkar S. Excellent response to combined radioiodine and enoxaparin in the setting of tumor venous thrombosis from differentiated thyroid carcinoma involving internal jugular and subclavian veins[J]. Future Oncol, 2013, 9(12):1813-1818.
|
[18] |
Nakayama R, Horiuchi K, Susa M, et al. Clinical outcome after bone metastasis (BM) surgery in patients with differentiated thyroid carcinoma (DTC): a retrospective study of 40 cases[J]. Jpn J Clin Oncol, 2014, 44(10):918-925.
|